Kyo Diagnostics
Personalized healthcare business based on sensitivity testing on anticancer drugs for colorectal cancer.
Kyo Diagnostics is a company in insurtech based in Tokyo, Japan.
Profile
"Kyo Diagnostics is a pioneering health and insurtech company specializing in personalized healthcare solutions. Utilizing advanced techniques to culture cancer stem cells from cancer tissue and Patient-Derived Spheroid Xenograft (PDSX) modeling technology, Kyo Diagnostics focuses on sensitivity testing for anticancer drugs, particularly for colorectal cancer. By offering tailored healthcare options based on individual patient needs and responses to treatment, Kyo Diagnostics aims to revolutionize cancer care and improve patient outcomes. The company's innovative approach to personalized medicine and drug testing showcases its commitment to advancing the field of oncology and providing cutting-edge solutions for patients and healthcare providers alike."
The company sits in the insurtech segment, where it competes on its core product or service.
The company is recorded as being based in Tokyo, Japan.
The company is listed at the Plug and Play accelerated startup stage of development.
| Sector | Insurtech |
|---|---|
| Headquarters | Tokyo, Japan |
| Country | Japan |
| Stage | Plug and Play accelerated startup |
Website: kyo-diagnostics.jp
Browse related
Create a free account